Live Breaking News & Updates on Unless Extended Further

Stay updated with breaking news from Unless extended further. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update

– Significantly Strengthened Balance Sheet in January 2024 with Execution of Three-Tranche Private Placement of up to $240 Million, Extending Cash Runway Into the Third Quarter of 2025 Based on. ....

United States , Edna Kaplan , Paula Schwartz , Jessica Breu , Daniel Vitt , Immunic Inc , Assembly Conference , Exchange Commission , Development Rd Expenses , Rx Communications Group , Association Of European Coeliac Societies , Program In Relapsing Multiple Sclerosis Ongoing , Trademark Office , Significantly Strengthened Balance Sheet , Three Tranche Private Placement , Extending Cash Runway Into , Third Quarter , Neuroprotective Activity , Vidofludimus Calcium , Consistent Across , Entire Progressive Multiple Sclerosis Population , All Subtypes , Relapsing Multiple Sclerosis Ongoing , Expanded Vidofludimus Calcium Patent Portfolio , Additional New Patents Granted , Exclusivity Protection Expected Into ,

EQS-News: Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update

EQS-News: Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Daniel Vitt , Jessica Breu , Paula Schwartz , Edna Kaplan , Immunic Inc , Assembly Conference , Rx Communications Group , Exchange Commission , Development Rd Expenses , Association Of European Coeliac Societies , Program In Relapsing Multiple Sclerosis Ongoing , Trademark Office , Distribution Services , Annual Results , Reports Year End , Provides Corporate Update , Provides Corporate , Strengthened Balance Sheet , Three Tranche Private Placement , Extending Cash Runway Into , Third Quarter , Neuroprotective Activity , Vidofludimus Calcium , Consistent Across , Entire Progressive Multiple Sclerosis Population ,

Immunic Highlights 2023 Accomplishments and Upcoming Milestones

Immunic Highlights 2023 Accomplishments and Upcoming Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Edna Kaplan , Hella Kohlhof , Richard Rudick , Daniel Vitt , Jessica Breu , Paula Schwartz , Program In Relapsing Multiple Sclerosis Ongoing , Prnewswire Immunic Inc , Jp Morgan Health Care Conference , Exchange Commission , Rx Communications Group , Corporate Community , Immunic Inc , International Business Gold Award , Improvements In Gut Health Demonstrated Phase , Neuroprotective Activity , Vidofludimus Calcium , Consistent Across , Entire Progressive Multiple Sclerosis Population , All Subtypes , Relapsing Multiple Sclerosis Ongoing , Gut Health Demonstrated , Clinical Trial , Celiac Disease ,

EQS-News: Immunic, Inc.: Immunic Highlights 2023 Accomplishments and Upcoming Milestones

EQS-News: Immunic, Inc.: Immunic Highlights 2023 Accomplishments and Upcoming Milestones
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Paula Schwartz , Daniel Vitt , Jessica Breu , Richard Rudick , Edna Kaplan , Hella Kohlhof , Exchange Commission , Jp Morgan Health Care Conference , Corporate Community , Immunic Inc Nasdaq , Program In Relapsing Multiple Sclerosis Ongoing , International Business Gold Award , Distribution Services , Immunic Inc , Improvements In Gut Health Demonstrated Phase , Rx Communications Group , Upcoming Milestones , Neuroprotective Activity , Vidofludimus Calcium , Consistent Across , Entire Progressive Multiple Sclerosis Population , All Subtypes , Relapsing Multiple Sclerosis Ongoing , Gut Health Demonstrated ,

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dosing Regimens in Multiple Sclerosis

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for. ....

United States , Edna Kaplan , Daniel Vitt , Jessica Breu , Paula Schwartz , Prnewswire Immunic Inc , Immunic Inc , Rx Communications Group , Trademark Office , Exchange Commission , Fundamental New Patent Covers Treatment , Multiple Sclerosis Into , Vidofludimus Calcium , Multiple Sclerosis , Unless Extended Further , Protecting Specific Dose Strength , Relapsing Multiple Sclerosis Treatment , United States Patent , Dosage Regimen , Chronic Inflammatory , Autoimmune Diseases , Patent Term Extension , Chief Executive Officer , Private Securities Litigation Reform Act , Middle East , Annual Report ,